Eli Lilly announces $7-billion merger for wakefulness drugs
Eli Lilly announces $7-billion merger, with eye on wakefulness drugs. The deal with London and Boston-based biotech company Centessa could have implications for treating Alzheimer’s. The post Eli Lilly announces $7-billion merger, with eye on wakefulness drugs appeared first on Mirror Indy.